Acumen Pharmaceuticals Inc (ABOS) Stock Price

1.89 ▲ +0.03 (+1.61%)
Open: 1.88 Vol: 305.42K Day's range: 1.83 - 1.99 Jan 16, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ABOS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY NEUTRAL NEUTRAL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.90▲ 1.90▲ 1.91▼ 1.80▲ 2.00▼
MA10 1.89▲ 1.92▼ 1.90▼ 1.86▲ 1.92▼
MA20 1.91▼ 1.89▲ 1.85▲ 1.99▼ 1.84▲
MA50 1.90▲ 1.81▲ 1.83▲ 1.92▼ 1.47▲
MA100 1.84▲ 1.85▲ 1.94▼ 1.82▲ 2.14▼
MA200 1.81▲ 1.99▼ 1.98▼ 1.51▲ 3.54▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.002▼ -0.005▼ 0.008▲ -0.023▼ -0.010▼
RSI 49.328▼ 56.015▲ 56.049▲ 47.598▼ 53.005▲
STOCH 88.889▲ 31.457     61.739     28.786     55.833    
WILL %R 0.000▲ -61.538     -33.333     -53.191     -59.375    
CCI 66.667     -34.046     29.686     -2.813     -59.290    
Latest Filters Detected On ABOS
CDL $ABOS Doji Star Candlestick Pattern Detected Set Alert
CDL $ABOS Doji Candlestick Pattern Detected Set Alert
Acumen Pharmaceuticals Inc News
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ Technology for Oligomer-Selective Antibodies and Recruitment Strategies for Phase 2 ALTITUDE-AD Clinical Trial at ...
Tuesday, December 02, 2025 04:59 AM
NEWTON, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid ...
Acumen Pharmaceuticals Announces First Participant Dosed in Phase 2 Open-Label Extension Study of Sabirnetug in People with Early Alzheimer’s Disease
Monday, November 17, 2025 12:00 AM
NEWTON, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid ...
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2025 Earnings Call Transcript
Thursday, November 13, 2025 12:17 AM
Acumen Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.43668, expectations were $-0.63. Operator: Good day, and welcome to the Acumen Pharma Third Quarter 2025 Conference Call ...
ABOS historical stock data
date open high low close volume
16/01/26 1.88 1.99 1.83 1.89 305,424
15/01/26 1.7397 1.88 1.73 1.86 127,522
14/01/26 1.74 1.84 1.729 1.79 221,300
13/01/26 1.72 1.7564 1.675 1.73 106,322
12/01/26 1.84 1.84 1.67 1.72 302,200
09/01/26 1.85 1.85 1.70 1.81 284,600
08/01/26 1.95 1.95 1.72 1.86 588,300
07/01/26 1.98 2.04 1.95 1.99 220,200
06/01/26 1.98 2.051 1.94 1.96 165,900
05/01/26 2.08 2.133 1.90 1.98 181,400
Quote Details
52wk Low:0.855
52wk High:2.46
Vol:305.42K
Avg Vol(3m):3.2M
1Y Chng:+27.70%
1M Chng:-4.55%
Add to Watch List
More Information
Index US Composite
Market Cap. 112.67M